{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-206578","form_type":"8-K","ticker":"LMAT","cik":"0001158895","company_name":"LEMAITRE VASCULAR INC","filed_at":"2026-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.014659+00:00","generated_at":"2026-05-14T23:13:43.553826+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"LeMaitre Q1 2026 sales $66.6M (+11%), EPS $0.68 (+42%); raises FY guidance","bullets":["Q1 sales $66.6M (up 11% YoY, 10% organic); gross margin 72.7% (+350 bps); EPS $0.68 (+42%).","Operating income $17.8M (+41%), op margin 27%; cash grew to $367.2M.","Artegraft grew 36% worldwide; records for grafts (+20%), valvulotomes (+15%), carotid shunts (+11%).","Quarterly dividend $0.25/share (payable June 4, record May 21); $100M share repurchase program active.","FY 2026 guidance: sales $277-283M (mid $280M, +12%), EPS $2.93-3.08 (mid $3.00, +26% adj.)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-206578","json":"https://secwatch.observer/filing/0001193125-26-206578.json","markdown":"https://secwatch.observer/filing/0001193125-26-206578.md","text":"https://secwatch.observer/filing/0001193125-26-206578.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/d94324d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T23:13:43.553826+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"18b35d6c4513f555ea14b7ef317f17e8fb286c74","claim":"LEMAITRE VASCULAR INC reported Q2 2026 results: revenue $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.), EPS $0.79 - $0.84 (Mid $0.81, +35%.). Guidance raised.","evidence_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","confidence":0.9},{"claim_id":"f53febc1b2bffe65d2039bcc7def7b2fece6e669","claim":"LEMAITRE VASCULAR INC reported Q1 2026 results: revenue Sales $66.6mm, EPS EPS $0.68.","evidence_excerpt":"LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q1 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. Q1 2026: • Sales $66.6mm, +11% (+10% organic) vs. Q1 2025 • Gross margin 72.7% (+350 bps) • Op. income $17.8mm (+41%) • Op. margin 27% • EPS $0.68 (+42%) • Cash up $8.1mm sequentially to $367.2mm","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","confidence":0.95}],"comparable_filings":[{"accession":"0001326380-26-000020","ticker":"GME","company_name":"GameStop Corp.","filed_at":"2026-06-02T20:43:35+00:00","headline":"GameStop Q1 record net income $389.6M, revenue up 14%, new $2B buyback","event_type":"earnings","sec_items":["2.02","7.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001326380-26-000020","json":"https://secwatch.observer/filing/0001326380-26-000020.json","markdown":"https://secwatch.observer/filing/0001326380-26-000020.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326380/000132638026000020/0001326380-26-000020-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326380/000132638026000020/gme-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","comparable_excerpt":"Net sales were $835.3 million for the first quarter","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1326380/000132638026000020/0001326380-26-000020-index.htm"}},{"accession":"0001628280-26-039805","ticker":"GTLB","company_name":"Gitlab Inc.","filed_at":"2026-06-02T20:17:31+00:00","headline":"GitLab Q1 revenue $264M (+23% YoY); plans 14% workforce cut, $30-35M charges","event_type":"earnings","sec_items":["2.02","2.05","7.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039805","json":"https://secwatch.observer/filing/0001628280-26-039805.json","markdown":"https://secwatch.observer/filing/0001628280-26-039805.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653482/000162828026039805/0001628280-26-039805-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653482/000162828026039805/gtlb-20260601.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","comparable_excerpt":"in such filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nGitLab Reports First Quarter Fiscal Year 2027 Financial Results First Quarter Fiscal Year 2027 Highlights: • Total revenue of $264.2 million, up 23% year-over-year • GAAP operating margin of (6)%; non-GAAP operating margin of 14% • Operating cash flow of $149.2 million and non-GAAP adjusted free cash flow of $146.7","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1653482/000162828026039805/0001628280-26-039805-index.htm"}},{"accession":"0001040130-26-000016","ticker":"PETS","company_name":"PETMED EXPRESS INC","filed_at":"2026-06-02T20:15:54+00:00","headline":"PetMed Q4 sales fall 15.6% to $42.8M; FY net loss widens to $57.3M on goodwill impairment","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001040130-26-000016","json":"https://secwatch.observer/filing/0001040130-26-000016.json","markdown":"https://secwatch.observer/filing/0001040130-26-000016.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000016/0001040130-26-000016-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000016/pets-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","comparable_excerpt":"Net sales of $179.0 million compared to $227.0 million in the prior year, a decrease of 21.1%, primarily driven by a decline in prescription medication sales. • Net loss of $57.3 million, or $(2.74) per diluted share, compared to a net loss of $6.3 million, or $(0.30) per diluted share in the prior year.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1040130/000104013026000016/0001040130-26-000016-index.htm"}},{"accession":"0001193125-26-253505","ticker":"SPWH","company_name":"SPORTSMAN'S WAREHOUSE HOLDINGS, INC.","filed_at":"2026-06-02T20:10:20+00:00","headline":"Sportsman's Warehouse Q1 net sales up 2.8% to $256.1M; same-store sales +2.1%; net loss $21.8M","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253505","json":"https://secwatch.observer/filing/0001193125-26-253505.json","markdown":"https://secwatch.observer/filing/0001193125-26-253505.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1132105/000119312526253505/0001193125-26-253505-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1132105/000119312526253505/spwh-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","comparable_excerpt":"and generating positive free cash flow to further strengthen our balance sheet through debt reduction.” For the thirteen weeks ended May 2, 2026: • Net sales increased 2.8% to $256.1 million, compared to $249.1 million in the first quarter of fiscal year 2025. Performance was driven primarily by a 7.4% gain in Hunting and Shooting Sports, led by firearms, ammunition,","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1132105/000119312526253505/0001193125-26-253505-index.htm"}},{"accession":"0001327567-26-000012","ticker":"PANW","company_name":"Palo Alto Networks Inc","filed_at":"2026-06-02T20:08:29+00:00","headline":"Palo Alto Networks Q3 revenue $3.0B (+31% YoY); NGS ARR $8.1B (+60% YoY)","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001327567-26-000012","json":"https://secwatch.observer/filing/0001327567-26-000012.json","markdown":"https://secwatch.observer/filing/0001327567-26-000012.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1327567/000132756726000012/0001327567-26-000012-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1327567/000132756726000012/panw-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","comparable_excerpt":"chief financial officer of Palo Alto Networks. Third Quarter Fiscal 2026 Financial Highlights • Total revenue for the fiscal third quarter 2026 grew 31% year over year to $3.0 billion. This includes $388 million from CyberArk and Chronosphere. • Next-Generation Security ARR for the fiscal third quarter 2026 grew 60% year over year to $8.1 billion. This","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1327567/000132756726000012/0001327567-26-000012-index.htm"}},{"accession":"0001104659-26-069464","ticker":"ULTA","company_name":"Ulta Beauty, Inc.","filed_at":"2026-06-02T20:06:38+00:00","headline":"Ulta Q1 net sales +11.1% to $3.16B, comps +5.3%; FY EPS guidance raised to $28.36-$28.80","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069464","json":"https://secwatch.observer/filing/0001104659-26-069464.json","markdown":"https://secwatch.observer/filing/0001104659-26-069464.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1403568/000110465926069464/0001104659-26-069464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1403568/000110465926069464/ulta-20260602x8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","comparable_excerpt":"compared to the same period ended May 3, 2025 : ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ 13 Weeks Ended ​ ​ May 2, ​ May 3, (Dollars in millions, except per share data) ​ 2026 ​ 2025 Net sales ​ $ 3,163.9 ​ $ 2,848.4 Comparable sales ​ ​ 5.3% ​ ​ 2.9% Gross profit (as a percentage of net sales) ​ ​ 40.1% ​ ​ 39.1% Selling, general and administrative expenses ​ $ 814.7 ​ $ 710.6","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1403568/000110465926069464/0001104659-26-069464-index.htm"}},{"accession":"0001628280-26-039786","ticker":"YEXT","company_name":"Yext, Inc.","filed_at":"2026-06-02T20:05:58+00:00","headline":"Yext Q1 FY27: Adj EBITDA margin 25%, ARR $440.8M; boosts buyback by $100M","event_type":"earnings","sec_items":["2.02","8.01","9.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039786","json":"https://secwatch.observer/filing/0001628280-26-039786.json","markdown":"https://secwatch.observer/filing/0001628280-26-039786.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1614178/000162828026039786/0001628280-26-039786-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1614178/000162828026039786/yext-20260602.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","comparable_excerpt":"Exchange Act, except as expressly set forth by specific reference in such a filing. \n\n--- EX-99.1 (EX-99.1) ---\n\nYext Announces First Quarter Fiscal 2027 Results – Revenue of $107.9 million – Net Income Per Share, basic, of $0.02 or non-GAAP Net Income Per Share of $0.15 – Adjusted EBITDA of $26.9 million, resulting in an Adjusted EBITDA margin of 25% – ARR of","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1614178/000162828026039786/0001628280-26-039786-index.htm"}},{"accession":"0001104659-26-069227","ticker":"YSWY","company_name":"Yesway, Inc.","filed_at":"2026-06-02T11:35:47+00:00","headline":"Yesway reports Q1 net income $30.2M, Adjusted EBITDA $59.2M; introduces FY2026 outlook","event_type":"earnings","sec_items":["2.02","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same fact type: earnings_release","same SEC item: 2.02, 9.01","same event type: earnings","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069227","json":"https://secwatch.observer/filing/0001104659-26-069227.json","markdown":"https://secwatch.observer/filing/0001104659-26-069227.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859836/000110465926069227/0001104659-26-069227-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859836/000110465926069227/tm2616553d1_8k.htm"},"side_by_side_evidence":{"fact_type":"earnings_release","source_excerpt":"Business Outlook Q2 2026 Guidance Full Year Guidance Sales $70.5mm - $72.5mm (Mid $71.5mm, +11%, +11% org.) $277mm - $283mm (Mid $280mm, +12%, +12% org.) Gross Margin 72.1% 72.3% Op. Income $20.8mm - $22.3mm (Mid $21.6mm, +34%) $77.6mm - $82.0mm (Mid $79.8mm, +18%, +24% adj.) Op. Margin (Mid) 30% 29% EPS $0.79 - $0.84 (Mid $0.81, +35%.) $2.93 - $3.08 (Mid $3.00, +19%, +26% adj.)","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1158895/000119312526206578/0001193125-26-206578-index.htm","comparable_excerpt":"On June 2, 2026, Yesway, Inc. issued a press release announcing its financial results for the three months ended March 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1859836/000110465926069227/0001104659-26-069227-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}